Delivery Order SPE2DB20D3103-SPE2DB25FM5U6

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,905.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,558,461,377 units of Doxycycline Mono 100 mg capsules, a generic antibiotic medication. The contract is a Firm Fixed Price Delivery Order with a completion date of September 15, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,283.49 firm fixed-price delivery order is for the supply of 4,566,178,214 units of doxycycline hyclate 100 mg capsules. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,678.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,049,919 units of doxycycline monohydrate 100 mg tablets, a common antibiotic used to treat various infections. This is a firm-fixed-price delivery order contract with a completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4,564,401,430 units of doxycycline monohydrate 100 mg capsules. The contract has a ceiling value of $9,869.40 and a term ending on April 26, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,619,033 units of Doxycycline Hyclate 100 mg capsules. The fixed-price delivery order, valued at $1,350.96, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,358.93, is for the delivery of 4,566,846,892 units of Doxycycline Hyclate 100 mg tablets with an ultimate completion date of January 7, 2025. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,135.70 firm fixed-price delivery order is for the supply of 4,566,882,298 units of Doxycycline Hyclate 100 mg tablets with an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $75,624.41, is for the delivery of 4,543,086,193 doxycycline 100mg tablets in packages of 500. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,046.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under an Indefinite Delivery Contract (IDC), is for the delivery of 4,566,678,454 units of Doxycycline Hyclate 50 mg capsules. The contract has a firm fixed price and has an ultimate completion date of December 11, 2024. There is no set-aside designation noted for...
This federal contract award, with ID SPE2DB22D3501|SPE2DB23FTR82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,255,906 units of doxycycline hyclate 100 mg tablets. The $1,644.16 firm-fixed-price delivery order has an ultimate completion date of December 5, 2022. This award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, holds significant...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM5U6
    Delivery Order

This federal contract award, valued at $2,441.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,155,189 units of Doxycycline Mono 100 mg capsules. The award is a firm-fixed-price delivery order with a completion date of February 5, 2025. This contract is not designated as a set-aside.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/6/25, 9:55 AM